DrugCore and RegulatoryCore are now live in the API and MCP. Read more

Amass

Amass *Core

Seven specialised data layers. One retrieval engine.

One query searches literature, patents, trials, drugs, regulatory docs, and live web in parallel. Every answer cites its source — a DOI, NCT ID, or patent number. No hallucination.

Architecture

How a query fans out and comes back cited

You send one natural-language query. The engine dispatches to every relevant layer simultaneously, merges results, and returns a single JSON response with citations attached to each claim.

Data Sources

PubMedUSPTOFDAClinicalTrialsOpenAlexWeb

Amass *Core Engine

BioMedCore

39M+

ScholarCore

233M+

PatentCore

170M+

RegulatoryCore

FDA + EMA

DrugCore

22K+

TrialCore

575K+

WebCore

Live

Cited Outputs

Reports·Cited Q&A·Alerts·JSON API

BioMedCore

PubMed & PMC papers indexed

BioMedCore

39M+ PubMed and PMC papers — full text, MeSH-indexed

  • Full PubMed and PubMed Central coverage — abstracts and full text
  • Citation counts, journal impact metrics, and quality signals
  • Ideal for systematic literature reviews and evidence synthesis
  • MeSH-enriched metadata for precise filtering
PubMedPMID 38420693

SGLT2 inhibitors in heart failure with preserved ejection fraction

Solomon SD, McMurray JJV, et al.

N Engl J Med (2024)

ScholarCore

Scholarly papers across all disciplines

ScholarCore

233M+ papers across every discipline — OpenAlex and Semantic Scholar

  • Conference papers, preprints, dissertations, and journal articles
  • Cross-disciplinary coverage from OpenAlex and Semantic Scholar
  • Author disambiguation and institutional affiliations
  • Citation graph traversal for influence mapping
Preprint412 cites

Foundation models for biomedical text mining: an empirical study

Ng, A., Bommasani, R., et al.

arXiv (2024)

PatentCore

Global patents indexed

PatentCore

170M+ patents — USPTO, EPO, WIPO — claims, families, and citations

  • USPTO, EPO, and WIPO coverage via Lens.org
  • Freedom-to-operate analysis and IP landscape mapping
  • Claims extraction, family grouping, and citation networks
  • Real-time monitoring for new filings in your domains
PatentWO2024/098321

Bispecific antibody constructs for CDK4/6 targets

Assignee: Roche Holding AG

Filed: 2023-11-14

RegulatoryCore

FDA & EMA documents indexed

RegulatoryCore

FDA and EMA on one schema — approvals, labels, EPARs, and designations

  • FDA application records, drug labels, review documents, and approval letters
  • EMA EPARs, assessment reports, and SmPCs — European authorizations in full
  • Unified authorization status, plus Breakthrough, PRIME, and Accelerated Approval designations
  • Orphan tracking, cross-linked to the drug each authorization covers in DrugCore
FDANDA 761248

Donanemab (Kisunla)

Early symptomatic Alzheimer's disease

Approved: 2024-07-02

DrugCore

ChEMBL drugs & molecules indexed

DrugCore

22K+ harmonized drugs and molecules — modality, clinical stage, and structure

  • ChEMBL-derived drug records — names, trade names, and synonyms, harmonized
  • Chemical structures with InChIKey and SMILES, plus modality classification
  • Highest clinical stage reached, from preclinical through approval
  • Parent/child relationships, cross-linked to trials, literature, and regulatory records
ProteinApprovedCHEMBL2108724

Semaglutide

Ozempic · Wegovy · Rybelsus

6 approved · 30 investigational

TrialCore

Clinical trials indexed

TrialCore

575K+ trials from ClinicalTrials.gov and EU CTR — status, endpoints, sponsor

  • Full ClinicalTrials.gov registry with AI-enhanced search
  • Enrollment status, endpoints, and sponsor intelligence
  • Phase, indication, and comparator filtering
  • Trial-to-publication linking for evidence completeness
Phase 3Active

NCT04931681

Semaglutide vs placebo in NASH with fibrosis

Sponsor: Novo Nordisk

WebCore

Live web sources cited in real time

WebCore

Real-time news, press releases, and company disclosures — cited as they happen

  • Real-time news, press releases, and company announcements
  • Company profiles, pipeline updates, and deal intelligence
  • Market intelligence and competitive landscape signals
  • AI agent synthesizes and cites web sources in real time
Press release2 hours ago

Eli Lilly announces positive Phase 3 readout for orforglipron in obesity

investor.lilly.com

Capabilities

What you get back from every query

Cited answers

Every claim traces back to a source document. Inline citations, not hallucinated references.

Unified retrieval

Query once. Seven layers respond in parallel. No need to stitch results across different databases.

Agent execution

Built-in agents plan multi-step research workflows, iterate on results, and deliver structured output.

Enterprise controls

Role-based access, audit logging, and data residency options for regulated environments.

API & MCP access

REST API for custom integrations. MCP server for Claude, ChatGPT, and Cursor — same engine, your interface.

Structured outputs

Tables, JSON, and tagged extracts. Get machine-readable results, not just paragraphs of text.

Get started

Query 500M+ documents from your terminal in five minutes

Get your first cited response in under five minutes. No prior knowledge of the data layers required.